Alzheon rais­es $100M; Re­gen­eron ends mid-stage tri­al

Plus, news about Gen­mab, BioN­Tech, Bris­tol My­ers Squibb, Bridge­Bio, Jun­shi, Tevo­gen, Ac­tu­ate, GSK, Ochre Bio, Evotec and ProKid­ney:

Alzheon rais­es $100M Se­ries E: The com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.